Virtual Reality 3D-Surgery Modeling to Enhance Head and Neck Cancer Surgery Quality
Preoperative Virtual Reality and 3D Pathologic Modeling as Treatment for Head and Neck Squamous Cell Carcinoma
Thomas Jefferson University
160 participants
Feb 4, 2022
INTERVENTIONAL
Conditions
Summary
This clinical trial studies the use of virtual reality technology and three dimensional surgery (3D-surgery) modeling to enhance current treatments in head and neck cancer surgery. Virtual reality 3D-surgery modeling may improve quality of surgical planning and interdisciplinary communication between surgeons and pathologists during the treatment of head and neck squamous cell cancer and ultimately increase the accuracy of planning, the quality of communication, and maximize the outcome patients with head and neck cancer experience throughout treatment.
Eligibility
Inclusion Criteria5
- Diagnosed with cancer of the head and neck (oral cavity, oropharynx, larynx, hypopharynx, T1-T4)
- Receiving treatment at Thomas Jefferson University - Center City by a fellowship-trained HNC surgeon
- Eligible for definitive resection
- Age \> 18
- Provide signed written informed consent document
Exclusion Criteria5
- Impaired judgement or those unable to provide informed consent
- Any factor that would place the patient at increased risk or preclude the individual's full compliance with or completion of the study
- Nasopharyngeal carcinoma
- Contraindications for surgery
- Enrollment in other clinical trial
Interventions
Undergo virtual reality imaging via VR/3D-CEPs
Receive standard of care
Undergo surgical resection
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05031910